Portland, OR, August 19, 2026 —

Oregon Health & Science University (OHSU) in Portland, Oregon, is undertaking a significant study to evaluate the long-term positive effects of psilocybin therapy, commonly known as magic mushroom therapy, for individuals experiencing mental health challenges.

The research initiative involves closely monitoring participants who have undergone treatment at licensed mushroom clinics. The primary objective is to determine how effective psilocybin is in alleviating symptoms associated with conditions such as depression, anxiety, and post-traumatic stress disorder (PTSD).

Preliminary results from the OHSU study indicate promising outcomes. A substantial number of participants have reported considerable reductions in the severity of their mental health issues. Furthermore, a majority of those involved in the study have experienced an overall improvement in their general well-being. The research also highlights a notably low incidence of adverse reactions among participants.

This pioneering research is being facilitated by a grant awarded by the National Institutes of Health (NIH). The findings from this study are anticipated to play a crucial role in fostering greater acceptance of psychedelic compounds within conventional medical practices. Ultimately, the work conducted by OHSU could contribute to the potential for FDA approval of psilocybin as a treatment, particularly for trauma-related conditions.

The study’s focus on long-term benefits aims to provide a comprehensive understanding of psilocybin’s therapeutic potential beyond immediate post-treatment effects. By tracking participants over an extended period, researchers are gathering data to assess the durability of treatment outcomes and to further identify any potential risks or benefits associated with this emerging therapeutic approach.



Story summarized from the original created by Julia Lopez on www.kptv.com, see more information here.

About The Author
SignalNewsAI